Skip to main navigation
Skip to search
Skip to main content
Johns Hopkins University Home
Home
Profiles
Research units
Research output
Search by expertise, name or affiliation
Study of Tofacitinib in Refractory Dermatomyositis: An Open-Label Pilot Study of Ten Patients
Julie J. Paik
,
Livia Casciola-Rosen
, Joseph Yusup Shin
,
Jemima Albayda
, Eleni Tiniakou
,
Doris G Leung
,
Laura Gutierrez-Alamillo
,
Jamie Perin
,
Liliana Florea
, Corina Antonescu
, Sherry G. Leung
, Grazyna Purwin
, Andrew Koenig
,
Lisa Christopher-Stine
School of Medicine
Kennedy Krieger Institute
Bloomberg School of Public Health
Research output
:
Contribution to journal
›
Article
›
peer-review
3
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Study of Tofacitinib in Refractory Dermatomyositis: An Open-Label Pilot Study of Ten Patients'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Pharmacology, Toxicology and Pharmaceutical Science
Dermatomyositis
100%
Tofacitinib
100%
Myositis
50%
Disease Activity
37%
Janus Kinase Inhibitor
37%
Disease
25%
Chemokine
25%
Rheumatic Disease
25%
Clinical Trial
12%
Randomized Controlled Trial
12%
Interferon
12%
Clinical Study
12%
Creatine Kinase
12%
RNA-Sequencing
12%
Immunology and Microbiology
Dermatomyositis
100%
Tofacitinib
100%
Myositis
50%
Chemokine
25%
STAT1
25%
Rheumatic Disease
25%
Gene Expression
12%
interferon
12%
CXCL10
12%
RNA Sequence
12%
CXCL9
12%
Keyphrases
Definition of Improvement
12%